甘李药业：关于甘精胰岛素注射液及其预填充注射笔获得埃塞俄比亚药品注册批件的公告

Core Viewpoint - Ganli Pharmaceutical has received approval from the Ethiopian Food and Drug Authority for its insulin products, indicating a significant step in expanding its market presence in Ethiopia [1]. Group 1 - The company announced the receipt of registration certificates for Glargine Insulin Injection and Glargine Insulin Injection Pre-filled Pen [1]. - The registration numbers for the products are 11865/13208/NMR/2025 and 11864/13210/NMR/2025, respectively [1].